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Retinopathy of prematurity (ROP) is a multifactorial vasoproliferative disorder of the retina and was first described by Terry in 1942 [1,2]. Approximately, 65% of 
infants with birth weight <1250 g and 80% of those with birth 
weight <1000 g develop some degree of ROP [3,4]. The incidence 
of ROP in the Indian population has been estimated to be up 
to 46% and is on the rise in this part of Asia due to increasing 
incidence of preterm deliveries [5-7]. Due to wide variability 
among populations, studies have provided only incomplete 
results [8,9]. Identifying risk factors for ROP will help to initiate 
corrective measures in a neonate at potential risk for developing 
ROP and hence the rationale behind the study.
METHODS
The study aimed to evaluate the risk factors for the development 
of ROP in preterm very low birth weight neonates. The study 
was a prospective, unmatched case–control study conducted in 
a tertiary care center in Kerala, India that was commenced after 
obtaining approval from the Institutional Ethics Committee.
The study was conducted in subjects admitted to the Neonatal 
Intensive Care Unit (NICU) after obtaining written informed 
consent from the parents. The inclusion criteria consisted of 
preterm babies (gestational age <34 weeks) weighing <1500 g 
who developed ROP of any severity. Neonates with congenital 
anomalies and those who did not satisfy the inclusion criteria 
were excluded from the study. Controls were defined as preterm 
babies (<34 weeks gestational age) weighing <1500 g admitted to 
NICU and who did not develop ROP.
The study was conducted for 18 months, and various risk 
factors for the development of ROP were analyzed. The maternal 
factors studied were the type of delivery, maternal fever, 
pregnancy-induced hypertension (PIH), gestational diabetes 
mellitus (GDM), cardiac disease, premature rupture of membrane 
(PROM), antepartum hemorrhage, chorioamnionitis, multiple 
pregnancy, infertility treatment, urinary tract infections (UTI), 
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polyhydramnios, and oligohydramnios. The neonatal factors 
studied were gestational age, birth weight, septicemia, apnea, 
anemia, hypotension, need for inotropic support, type and duration 
of oxygen therapy, patent ductus arteriosus (PDA), necrotizing 
enterocolitis, intraventricular hemorrhage, and phototherapy. All 
the relevant clinical and biochemical data required for the study 
were obtained.
Birth asphyxia defined by WHO as failure to initiate and 
maintain spontaneous respiration was determined using the 
APGAR score. Apnea was defined as cessation of respiration for 
>20 s or cessation of respiration of any duration accompanied 
by bradycardia (heart rate <100/min) and/or cyanosis. Sepsis 
was diagnosed clinically by common signs such as hyperthermia 
or hypothermia, respiratory distress, apnea, cyanosis, jaundice, 
hepatomegaly, abdominal distension, feeding abnormalities, and 
neurological abnormalities like seizures. The same was supported 
by laboratory evidence such as micro erythrocyte sedimentation 
rate, C-reactive protein, absolute neutrophil count and blood 
culture, urine culture, and cerebrospinal fluid analysis. PDA was 
diagnosed clinically and by echocardiography. Intraventricular 
hemorrhage was diagnosed by cranial ultrasonography. 
Hypotension was defined by a combination of criteria defined 
as mean blood pressure less than gestational age in weeks with 
evidence of poor systemic perfusion defined as a prolonged 
capillary refill time >3 s [10,11]. Hyperbilirubinemia and hours 
of phototherapy and units of packed red blood cell transfusion 
were noted. Details of oxygen administration, duration, and mode 
of oxygen administration were also recorded.
All the preterm babies who were admitted to the NICU 
satisfying the study criteria were referred to the Department of 
Ophthalmology in the same institute at 4 weeks of postnatal age. 
Screening for ROP was done by an experienced ophthalmologist. 
The eye was dilated using 1% tropicamide and 2.5% phenylephrine 
drops. After half an hour, the eye was examined with indirect 
ophthalmoscope with a 20–diopter lens. No local anesthesia was 
used during the procedure. ROP was classified, according to the 
international classification of ROP criteria, location as zone 1, 2, 
3 extended in clock hours and severity as Stage 1, 2, 3, 4 and 5. 
Threshold stage ROP/pre-threshold ROP was also noted.
Stages 1 and 2 ROP were usually followed every week/2 weeks 
until resolution or progression to more advanced stage. Stages 
3, 4 and 5 ROP were treated by/advised intervention such 
as laser/surgery. Cryotherapy and diode laser therapy were 
the usual mode of treatment for threshold ROP and those 
requiring interventions were referred to higher center for further 
management. Those without ROP were re-examined every 
2 weeks. Furthermore, Stages 1 and 2 were followed weekly and 
more frequently in those with ROP stage 3 and above. Babies 
were then reviewed in the newborn follow-up clinic.
Statistical Analysis
Based on a previous study, the odds ratio of low gestational age 
for the development of ROP in the premature babies was 3.1 [12]. 
The sample size thus calculated based on the study was 108 with 
54 cases and 54 controls (1:1). The quantitative variables under the 
study were described by mean with its 95% confidence intervals 
(CIs) and qualitative variables with frequencies and proportions. 
Chi-square test was used in case of categorical variables. Binary 
logistic regression was used to find out independent predictors 
of the outcome. The odds ratio with its CI given by the model 
was taken as the strength of association in the final analysis. The 
analysis was done using SPSS software in coordination with the 
Department of Community Medicine of the same institute.
RESULTS
A total of 108 cases were enrolled with cases and controls in a 
ratio of 1:1. Fig. 1 shows the study disposition, and Table 1 shows 
the various baseline demographic and clinical characteristics. 
Male subjects predominated the study. The majority of the cases 
as well as controls had a birth weight <1200 g. All the subjects 
in the study population had a gestational age between 28 and 
34 weeks. Various risk factors in mother and baby were studied 
for the strength of association with ROP. None of the mothers had 
maternal fever, chorioamnionitis, or polyhydramnios. The various 
modes and duration of oxygen administration and its association 
with ROP were also studied (Fig. 2 and Table 2).
Univariate analysis revealed gestational age, PIH, birth 
weight, sepsis, oxygen administration, hypotension, and packed 
cell transfusion as important risk factors for ROP. On multivariate 
binary logistic regression, birth weight (odds ratio: 6.00; p: 0.014), 
oxygen exposure (odds ratio: 11.05; p: 0.003), and hypotension 
(odds ratio: 6.85; p: 0.009) were identified as important risk 
predictors of ROP (Table 3). Approximately one-quarter of neonates 
(Table 1) affected with ROP required intervention and were 
 referred to higher center for the same.
DISCUSSION
ROP has been found to be an important cause of childhood visual 
impairment and blindness and affects the normal motor, language 
and social development of the child. Retinal vascularization starts 
at around 15th week of gestation and is completed by around 
36 weeks in the nasal side and by term in the larger temporal 
side [13]. Central to the pathogenesis of ROP is interference with 
the normal maturation of the retina secondary to factors such as 
hyperoxia and angiogenic factors like vascular endothelial growth 
factor.
ROP incidence is inversely related to birth weight and 
gestational age, and studies have shown that 80% of infants 
with birth weight <1000 g show some evidence of ROP [14,15]. 
Similar findings were replicated in our study also where 90.7% 
of babies with birth weight of <1200 g developed ROP. Although 
decreasing birth weight has been associated with both incidence 
and severity of ROP, decreasing gestational age is only associated 
with incidence of ROP. No major studies till date have proven to 
have a gender preference with the occurrence of ROP. Our study 
showed that the incidence of ROP was more in male infants, but 
was not significant (p=0.243).
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Maternal factors play a major part in determining pregnancy 
outcomes, and hence, were studied for association with incidence 
of ROP. Several putative factors such as type of delivery, maternal 
fever, PIH, GDM, UTI, cardiac disease, PROM, chorioamnionitis, 
antepartum hemorrhage, multiple pregnancy, infertility treatment, 
polyhydramnios, and oligohydramnios were considered. 
Although PIH was found to have a positive association with the 
development of ROP in univariate analysis (Table 1; p=0.008), 
multivariate analysis failed to prove the same (Table 3; p=0.157). 
Maternal pre-eclampsia has been found to have a protective effect 
against development of ROP in various studies. Hypertension 
causes intrauterine stress and subsequent maturation of the eyes. 
Treatment for infertility, PROM, GDM, and mode of delivery 
were not found to be associated with the development of ROP in 
this study. However, studies have proven otherwise also [16]. Of 
late, babies conceived via in vitro fertilization have been found to 
have an increased incidence of ROP, probably due to the higher 
incidence of preterm delivery and multiple pregnancies associated 
with the same.
Just like the maternal factors and even more important in the 
pathogenesis of ROP is the role played by neonatal factors. It is 
very well proven that high inspired oxygen is an important risk 
factor for ROP [17,18] and strict control of oxygen exposure 
during the neonatal period is associated with lower incidence of 
ROP [19-23]. In our study, it was noted that 96.3% of the cases 
had been exposed to oxygen as compared to 55.6% of the controls 
([p=0.000]; odds ratio=20.8 [95% CI 4.59-94.24]). Several 
theories such as free radical injury, stimulation of vasogenic 
factors, and physiologic differences between choroidal and 
retinal circulations have been hypothesized for the development 
of ROP in those with increased oxygen exposure. Both the mode 
and duration of oxygen administration were also taken into 
consideration (Table 2).
Of the various other risk factors, sepsis [24], hypotension [25], 
and blood transfusion [26,27] were found to have significant 
association with the occurrence of ROP (Table 1). The hypothesized 
reason for the higher rates of ROP in these settings has been 
inflammation and subsequent free radical injury associated 
Figure 1: Study disposition
Figure 2: Modes of oxygen exposure: Percentages in the study 
population
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proven in our study and warrants further research [28-31]. In our 
study, the factors which were found to be significant on univariate 
analysis were maternal PIH, birth weight, gestational age, oxygen 
administration, blood transfusion, hypotension, and systemic 
infection. The factors found to be significant on univariate 
analysis were subjected to a multivariate analysis using binary 
logistic regression analysis. A model was constructed in which 
37.8% of the factors contributing to the occurrence of ROP could 
be predicted. Gestational age had strong correlation with birth 
weight (correlation coefficient = 1) and hence was omitted from 
the model. Birth weight, oxygen exposure, and hypotension were 
found to be significant risk predictors of ROP (Table 3).
Nearly a quarter of neonates affected with ROP needed 
interventions due to their advanced stage. The prevalence of most 
of the risk factors in those with severe stages of ROP (stage III 
and above) were  found to be significantly higher than those 
with lesser stages (Table 1). They were referred to higher tertiary 
care institute for further management and follow-up. Judicious 
use of oxygen and blood products in premature low birth weight 
Table 2: Duration of oxygen administration
O2 duration Cases (%) Control (%) Total (%)
>6 days 30 (55.6) 5 (9.3) 35 (32.4)
4-6 days 17 (31.5) 9 (16.7) 26 (24.1)
1-3 days 5 (9.3) 16 (29.6) 21 (19.4)
None 2 (3.7) 24 (44.4) 26 (24.1)
Table 3: Multivariate logistic binary regression analysis
Factor Adjusted odds ratio (95% CI) p value
Birth weight 6.00 (1.44-24.97) 0.014
O2 administration 11.05 (2.28-53.66) 0.003
Sepsis 1.49 (0.45-4.92) 0.521
Hypotension 6.85 (1.62-29.01) 0.009
Blood transfusion 2.029 (0.49-8.37) 0.328
Maternal PIH 5.633 (0.52-61.59) 0.157
PIH: Pregnancy induced hypertension, CI: Confidence interval, *p<0.05
with the same. The association of PDA, apnea, phototherapy 
and hyperbilirubinemia with the incidence of ROP could not be 
Table 1: Baseline characteristics of the study population
Variable Cases (n=54) (%) Severe ROP cases: 
Stage III and above (n=13)
Controls (n=54) (%) p value* (total cases 
versus controls)
Sex
Male 63 72 52 0.243
Female 37 28 48
ROP stages
I 54 - - -
II 22 - - -
III 18.5 - - -
IV 5.5 - - -
V - - - -
Maternal risk factors
Vaginal delivery 63 62 72 0.270
Gestational age
28-32 weeks 51.9 76 29.6 0.001
32-34 weeks 48.1 24 70.4
PIH 16.7 25 1.9 0.008
PROM 40.7 42 24.1 0.064
GDM 33.3 31 25.9 0.399
Infertility treatment 11.1 20 7.4 0.507
Neonatal risk factors
Birth weight≤1200 g 90.7 92 70.4 0.007
1201-1500 g 9.3 8 29.6
Septicemia 33.3 40 16.7 0.046
Hypotension 42.6 60 5.6 0.000
Packed cell transfusion 25.9 33 7.4 0.010
Oxygen administration 96.3 100 55.6 0.000
Apnea 27.8 40 16.7 0.165
Birth asphyxia 16.7 25 11.1 0.404
NEC 16.7 14 5.6 0.066
Phototherapy 40.7 50 48.1 0.439
ROP: Retinopathy of prematurity, PIH: Pregnancy induced hypertension, PROM: Premature rupture of membrane, GDM: Gestational diabetes mellitus, NEC: Necrotizing 
enterocolitis, *p<0.05
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neonates, optimal management of blood pressure, and institution 
of neonatal screening programs for ROP will all do a lot in the 
long run and help in improving outcomes.
There were certain limitations in our study. The study 
design - unmatched case–control type - by itself has its own 
limitations. Genetic factors were not taken into consideration due 
to lack of infrastructure for the same. Larger studies in similar 
populations are needed to validate the findings of this study 
and delineate the intricacies of the disease further. Since it was 
mainly a cross-sectional data analysis, long-term follow-up 
was not performed. Similarly, follow-up of infants referred for 
interventions could not be performed due to technical limitations.
CONCLUSIONS
In the present era of advanced neonatal care and management 
where the incidence of ROP is on the rise, identifying risk 
predictors helps in better understanding of the disease. Although 
active interventions toward the same have not yielded promising 
results still search is on to tackle the menace of ROP that is on the 
rise. This study has identified birth weight, oxygen administration 
and low blood pressure as major predictors of ROP and adds 
important information to the present day knowledge of ROP.
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